A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Acalabrutinib Impurity 12 - Request Quote

Picture of Acalabrutinib Impurity 12

Acalabrutinib Impurity 12

SZ CAT No:SZ-A078016
CAS No
NA
Mol.F.
C26H23N7O3
Mol.Wt.
481.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Acalabrutinib Impurity 12 is chemically (S)-8-Amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)-1-(4-(pyridin-2-ylcarbamoyl)phenyl)imidazo[1,5-a]pyrazine 7-oxide. Acalabrutinib Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Acalabrutinib Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Acalabrutinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Acalabrutinib Impurity 12

Purchase Acalabrutinib Impurity 12

Acalabrutinib Impurity 12 suppliers

Acalabrutinib Impurity 12 manufacturers

Acalabrutinib Impurity 12 price

Order Acalabrutinib Impurity 12

Enquire Acalabrutinib Impurity 12

Acalabrutinib Impurity 12 cost

Acalabrutinib Impurity 12 Supplier

Acalabrutinib Impurity 12 Distributor

Acalabrutinib Impurity 12 for Method Validation

Acalabrutinib Reference Standard

Acalabrutinib Impurity 12 for ANDA Filing

Acalabrutinib Impurity 12 for Forced Degradation Studies

Acalabrutinib Impurity 12 Identification Standards

Acalabrutinib Impurity 12 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,